VILON INJECTOR PEN 3ML

Vilon (Lys-Glu / KE): The Shortest Active Thymic Dipeptide Bioregulator for Immune Renewal, T-Cell Optimization, and Immunosenescence Research — Now Available in the UAE

Vilon, which is chemically defined as the dipeptide Lys-Glu (KE), is currently recognized as the shortest bioactive bioregulatory molecule within the peptide family developed by Dr. Vladimir Khavinson and his team at the St. Petersburg Institute of Bioregulation and Gerontology.

Vilon was created using amino acid analysis from naturally occurring thymic extracts, including Thymalin. Although composed of only two amino acids, Vilon has shown great tissue specificity toward the thymus and toward immune cells; it provides one of the most effective ways to conduct research.

Upon penetrating the nuclear membrane, Vilon directly interacts with specific areas of gene promoters and chromatin structures. By inducing deheterochromatinization (i.e., the activation of dormant chromatin) Vilon stimulates the expression of ribosomal genes and increases transcription of immune-related genes that are normally silent due to either age-related factors or immunosuppressive influences. As a result, this promotes better functioning of thymic epithelial cells, improves the rate of T-lymphocyte differentiation and proliferation, and ultimately results in enhanced adaptive and innate immunity.

The small size yet high potency of Vilon makes it an extremely useful tool for studying the biological process of immuno-senescence, the involution of the thymus, post-infectious immune response, autoimmune regulation, the ability of elderly individuals to respond to vaccines, and other approaches aimed at extending life span. In addition, preclinical data also indicate Vilon’s involvement in increased rates of cellular division, changes in chromatin configuration, and potentially extends longevity in certain animal models.

Our premium Vilon injection pen includes 3 ml of high purity (>99%) dipeptide solution, prepared under strict quality control procedures. The provided delivery system allows for convenient, easy-to-administer subcutaneous administration of precise dosages of Vilon to support a variety of research protocols associated with advanced immunology, gerontology, and epigenetics. The pen-based delivery system allows for both shorter term intense investigation and long term cyclical study while providing maximal protection against degradation of peptides.

Below, explore six key research-supported potential benefits of Vilon, grounded in mechanistic preclinical data, cellular studies, and Khavinson bioregulator science.

1. Stimulation of T-Lymphocyte Proliferation and Maturation
T-lymphocyte proliferation and differentiation is enhanced in a manner that stimulates the thymus epithelium, which results in increased numbers of CD3+, CD4+, and CD8+ T-lymphocytes and also differentiates the T-cells with an increase in expression of other differentiation markers, including CD5. In addition, Vilon has been shown to enhance the proliferative response to mitogen stimulation in both cultured aged human lymphocytes and various animal models; enhancing their ability to mount an adaptive immune response.

2. Counteraction of Thymic Involution and Regeneration Support
Vilon has a direct impact on the age related atrophy or “involution” of the thymus (the primary site where T lymphocytes are produced). The thymic epithelial cells are stimulated to express the genes that are important for T-lymphocyte development, while the developing thymocytes are converted into proliferative blast cells. This stimulation supports some degree of restitution of the original cellular structure and organization of the thymus. The effects of Vilon’s ability to support a thymotropic response addresses an underlying reason for many of the immune changes associated with aging.

3. Enhancement of Innate Immune Functions
Beyond adaptive immunity, Vilon boosts natural killer (NK) cell cytotoxicity and macrophage phagocytic activity. It improves overall innate defense readiness and supports phagocyte functions such as endocytosis and chemotaxis. These effects strengthen first-line immune responses, valuable for research on innate-adaptive crosstalk and immunocompromised states.

4. Targeted Reversal of Immunosenescence
Vilon addresses immunosenescence by reactivating silenced immune genes, improving chromatin accessibility, and restoring youthful immune profiles. It helps maintain naive T-cell populations and overall immune vigilance. Longitudinal animal studies show sustained immune function, reduced infection susceptibility, and potential lifespan extension, positioning Vilon as a key geroprotective research compound.

5. Accelerated Post-Infection and Post-Stress Immune Recovery
Vilon rapidly mobilizes T-cell populations and stabilizes immune signaling after severe bacterial, viral, or other immunosuppressive challenges. It supports faster lymphocyte recovery and normalization of immune markers. This makes it suitable for research on post-viral syndromes, sepsis recovery, chemotherapy/radiation support, and immune reconstitution protocols.

6. Chromatin Remodeling and Broader Cellular Anti-Aging Effects
Vilon induces selective deheterochromatinization of facultative heterochromatin without affecting structural pericentromeric regions. It activates ribosomal genes and supports telomere maintenance in lymphocytes. These epigenetic actions contribute to cellular rejuvenation and may underlie its broader geroprotective potential across immune and other tissues.

Why Choose Our Vilon Injector Pen?

The manufacturer of our VILON product has experience synthesizing peptides as per the methods described by Khavinson. Additionally, we conduct quality assurance tests using third party laboratories for each of the following factors: purity, potency, identity, sterility and stability. In addition to these tests, we verify every lot for compliance with the stringent requirements for reproducibility in sensitive aging and immunology studies.

Our precision engineered injector pen design makes administering subcutaneously easy (with no waste), allows for precise dose control, stores well and can be used for continuous or cyclical treatment as may be required in either a laboratory setting or during investigation.

We believe that our example of VILON is an illustration of how simple designs can produce powerful results in biological regulation. As the shortest known active peptide to stimulate Khavinson’s peptides, VILON gives researchers a very effective method to study the mechanisms of immune regeneration, chromatin dynamic processes and other aspects of normal aging processes at the molecular level.

Important Note: This product is intended strictly for research and laboratory use only. It is not for personal consumption, human or animal therapeutic use, or any clinical application. Please consult and fully comply with all local regulations in the UAE before purchasing or handling.